Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease
The University of Texas Health Science Center, Houston · NCT04005976
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Any age listed · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 5000
- US sites recruiting
- 14
- Study start
- June 15, 2016
- Record last updated
- February 2, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The Montalcino Aortic Consortium (MAC) will provide the infrastructure to assemble large cohorts of patients with mutations in known heritable thoracic aortic disease (H-TAD) genes, define the phenotype associated with these genes, and determine genetic and environmental modifiers of H-TAD.
Conditions: Aortic Aneurysm; Aortic Dissection; Aortic Diseases
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Patients and their relatives with a confirmed pathogenic, likely pathogenic variant, or variant of unknown clinical significance in at least one of the H-TAD genes (i.e. TGFBR1, TGFBR2, SMAD3, TGFB2, TGFB3, ACTA2, MYH11, MYLK, PRKG1, MAT2A, MFAP5, LOX, COL3A1, FOXE3, and FBN1).
- Patients of all ages, sex and race for which informed consent can be obtained.
Exclusion Criteria
- Patients without a confirmed causative variant for H-TAD.
Recruiting US locations
HOAG memorial hospital presbyterian
Newport Beach, CA 92663
Site contact: Site Investigator · 949-650-3350
Hoag Memorial Hospital Presbyterian
Newport Beach, CA 92663
Site contact: Chelsey Torres, MD · Chelsey.torres@hoag.org
Sutter Health
Sacramento, CA 95816
Site contact: Matthew Solomon, MD · matthew.solomon2@sutterhealth.org
University of Kentucky
Lexington, KY 40536
Site contact: Mary Sheppard · mary.sheppard@uky.edu
Massachusetts General Hospital
Boston, MA 02114
Site contact: Mark Lindsay, MD · Lindsay.Mark@mgh.harvard.edu
University of Michigan
Ann Arbor, MI 48109
Site contact: Marion Hofmann, MD · mhofmann@med.umich.edu
Washington University in St. Louis
St Louis, MO 63110
Site contact: Leslie Boyer · leslieboyer@wustl.edu
University of Nebraska Medical Center
Omaha, NE 68198
Site contact: Kelly Erickson · kelly.erickson@unmc.edu
St. Francis Hospital (Catholic Health)
Roslyn, NY 11576
Site contact: Timothy Carter · timothy.carter@chsli.org
Oregon Health & Science University
Portland, OR 97239
Site contact: Sherene Shalhub, MD · shalhub@ohsu.edu
Baylor College of Medicine
Houston, TX 77030
Site contact: Ginger Etheridge · Ginger.Etheridge@bcm.edu
Texas Children's Hospital
Houston, TX 77030
Site contact: Shaine Morris, MD · shainem@bcm.edu
The University of Texas Health Science Center at Houston
Houston, TX 77030
Site contact: Program Manager · 713-500-7386
Inova Health System
Falls Church, VA 22042
Site contact: Christopher Jordan, MD · Christopher.Jordan@inova.org
Study contacts (from the official record)
- Dianna M Milewicz, MD, PhD · 713-500-6725 · Dianna.M.Milewicz@uth.tmc.edu
- Ernesto Calderon Martinez, MD · (713) 500-6715 · Ernesto.CalderonMartinez@uth.tmc.edu
Similar studies in California
All healthy volunteers studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- Rialto, CA + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Lake Forest, CA + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Phase 1 Study of SBS-147 in Healthy Adults
Sparian Biosciences, Inc
- Location
- Cypress, CA
- Eligibility basics
- Ages 18–55